MiniMed director Lofton files initial Form 3

MiniMed Group, Inc. director Kevin E. Lofton filed an initial Form 3 reporting his status as an insider of the company.

Rhea-AI Filing Summary

MiniMed Group, Inc. director Kevin E. Lofton filed an initial Form 3 reporting his status as an insider of the company. The filing does not list any common stock or derivative holdings and shows no reported purchases, sales, exercises, gifts, or other transactions.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the MiniMed Group (MMED) Form 3 filing by Kevin E. Lofton show?

The Form 3 shows that Kevin E. Lofton is a director of MiniMed Group, Inc. It reports no transactions, no common stock trades, and no derivative positions, serving solely as an initial statement of insider status.

Did Kevin E. Lofton buy or sell MiniMed Group (MMED) shares in this Form 3?

No, the Form 3 reports zero purchases, zero sales, and no other share transactions. All transaction counts and share amounts, including buys, sells, exercises, gifts, and tax withholdings, are listed as zero in the summary fields.

Are any stock options or derivatives reported for MiniMed Group (MMED) in this Form 3?

No derivative positions are reported in this Form 3. The derivativeSummary section is empty, and the transactionSummary shows zero derivative transactions and zero exercised shares, indicating no options or similar instruments are disclosed here.

What insider role is disclosed for Kevin E. Lofton at MiniMed Group (MMED)?

The filing identifies Kevin E. Lofton as a director of MiniMed Group, Inc. It does not list him as an officer or ten percent owner, and it provides no additional titles or other roles beyond his directorship.

Does the MiniMed Group (MMED) Form 3 include any beneficial ownership footnote details?

The Form 3 includes a footnotes section, but it contains no substantive text. There are no stated disclaimers about voting or investment power and no references to related entities such as trusts, partnerships, or family investment vehicles.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/06/2026 - 06:14 PM EST Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Lofton Kevin E

(Last) (First) (Middle)

C/O 18000 DEVONSHIRE STREET

(Street)

NORTHRIDGE CA 91325

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/06/2026

3. Issuer Name and Ticker or Trading Symbol
MiniMed Group, Inc. [ MMED ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Bryan F. Kelly, attorney-in-fact	03/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.